These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 31697973)

  • 21. Meta-analysis of efficacy and treatment-emergent suicidality in adults by psychiatric indication and age subgroup following initiation of paroxetine therapy: a complete set of randomized placebo-controlled trials.
    Carpenter DJ; Fong R; Kraus JE; Davies JT; Moore C; Thase ME
    J Clin Psychiatry; 2011 Nov; 72(11):1503-14. PubMed ID: 21367354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complementary and alternative medicine for major depressive disorder: a meta-analysis of patient characteristics, placebo-response rates, and treatment outcomes relative to standard antidepressants.
    Freeman MP; Mischoulon D; Tedeschini E; Goodness T; Cohen LS; Fava M; Papakostas GI
    J Clin Psychiatry; 2010 Jun; 71(6):682-8. PubMed ID: 20573327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adjuvant therapy with antidepressants for the management of inflammatory bowel disease.
    Mikocka-Walus A; Prady SL; Pollok J; Esterman AJ; Gordon AL; Knowles S; Andrews JM
    Cochrane Database Syst Rev; 2019 Apr; 4(4):CD012680. PubMed ID: 30977111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis.
    Cipriani A; Furukawa TA; Salanti G; Chaimani A; Atkinson LZ; Ogawa Y; Leucht S; Ruhe HG; Turner EH; Higgins JPT; Egger M; Takeshima N; Hayasaka Y; Imai H; Shinohara K; Tajika A; Ioannidis JPA; Geddes JR
    Lancet; 2018 Apr; 391(10128):1357-1366. PubMed ID: 29477251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and efficacy of adjunctive second-generation antidepressant therapy with a mood stabiliser or an atypical antipsychotic in acute bipolar depression: a systematic review and meta-analysis of randomised placebo-controlled trials.
    McGirr A; Vöhringer PA; Ghaemi SN; Lam RW; Yatham LN
    Lancet Psychiatry; 2016 Dec; 3(12):1138-1146. PubMed ID: 28100425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antidepressant Efficacy for Depression in Children and Adolescents: Industry- and NIMH-Funded Studies.
    Walkup JT
    Am J Psychiatry; 2017 May; 174(5):430-437. PubMed ID: 28253735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Second-generation antipsychotics for obsessive compulsive disorder.
    Komossa K; Depping AM; Meyer M; Kissling W; Leucht S
    Cochrane Database Syst Rev; 2010 Dec; (12):CD008141. PubMed ID: 21154394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does the presence of an open-label antidepressant treatment period influence study outcome in clinical trials examining augmentation/combination strategies in treatment partial responders/nonresponders with major depressive disorder?
    Iovieno N; Papakostas GI
    J Clin Psychiatry; 2012 May; 73(5):676-83. PubMed ID: 22569112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Why has the antidepressant-placebo difference in antidepressant clinical trials diminished over the past three decades?
    Khan A; Bhat A; Kolts R; Thase ME; Brown W
    CNS Neurosci Ther; 2010 Aug; 16(4):217-26. PubMed ID: 20406269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dropout Prevalence and Associated Factors in Randomized Clinical Trials of Adolescents Treated for Depression: Systematic Review and Meta-analysis.
    Rohden AI; Benchaya MC; Camargo RS; Moreira TC; Barros HMT; Ferigolo M
    Clin Ther; 2017 May; 39(5):971-992.e4. PubMed ID: 28476404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design makes a difference: a meta-analysis of antidepressant response rates in placebo-controlled versus comparator trials in late-life depression.
    Sneed JR; Rutherford BR; Rindskopf D; Lane DT; Sackeim HA; Roose SP
    Am J Geriatr Psychiatry; 2008 Jan; 16(1):65-73. PubMed ID: 17998306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antidepressants for depression in medical illness.
    Gill D; Hatcher S
    Cochrane Database Syst Rev; 2000; (4):CD001312. PubMed ID: 11034712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anxiety does not predict response to antidepressant treatment in late life depression: results of a meta-analysis.
    Nelson JC; Delucchi K; Schneider LS
    Int J Geriatr Psychiatry; 2009 May; 24(5):539-44. PubMed ID: 19334041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.
    Benazzi F; Berk M; Frye MA; Wang W; Barraco A; Tohen M
    J Clin Psychiatry; 2009 Oct; 70(10):1424-31. PubMed ID: 19906346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of baseline severity on antidepressant efficacy for anxiety disorders: meta-analysis and meta-regression.
    de Vries YA; de Jonge P; van den Heuvel E; Turner EH; Roest AM
    Br J Psychiatry; 2016 Jun; 208(6):515-21. PubMed ID: 26989093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescents.
    Cox GR; Callahan P; Churchill R; Hunot V; Merry SN; Parker AG; Hetrick SE
    Cochrane Database Syst Rev; 2012 Nov; 11():CD008324. PubMed ID: 23152255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relapse prevention and residual symptoms: a closer analysis of placebo-controlled continuation studies with escitalopram in major depressive disorder, generalized anxiety disorder, social anxiety disorder, and obsessive-compulsive disorder.
    Bech P; Lönn SL; Overø KF
    J Clin Psychiatry; 2010 Feb; 71(2):121-9. PubMed ID: 19961809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of depression--newer pharmacotherapies.
    Mulrow CD; Williams JW; Trivedi M; Chiquette E; Aguilar C; Cornell JE; Badgett R; Noël PH; Lawrence V; Lee S; Luther M; Ramirez G; Richardson WS; Stamm K
    Psychopharmacol Bull; 1998; 34(4):409-795. PubMed ID: 10513454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Meta-analysis: Risk of hyperhidrosis with second-generation antidepressants.
    Beyer C; Cappetta K; Johnson JA; Bloch MH
    Depress Anxiety; 2017 Dec; 34(12):1134-1146. PubMed ID: 28881483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Meta-analysis: Risk of dry mouth with second generation antidepressants.
    Cappetta K; Beyer C; Johnson JA; Bloch MH
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun; 84(Pt A):282-293. PubMed ID: 29274375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.